Role of Transposable Elements in Septic Immune Aging
NCT06809868 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 116
Last updated 2026-01-30
Summary
The goal of this observational study is to learn about how transposable element levels affect the patient outcomes in sepsis. The main questions it aims to answer is:
1. Do transposable elements prematurely age the immune systems of patients with sepsis?
2. Do transposable elements correlate with increased mortality in patients with sepsis in the ICU?
3. Do transposable elements correlate with increased amount of secondary infections in patients with sepsis in the ICU?
Participants will have blood drawn from them but will not be subjected to additional interventions.
Conditions
- Sepsis
- Sepsis and Septic Shock
- Sepsis With Multiple Organ Dysfunction (MOD)
- Sepsis With Acute Organ Dysfunction
- Sepsis, Severe
- Sepsis at Intensive Care Unit
- Sepsis, Severe Sepsis and Septic Shock
- Sepsis, Septic Shock
Interventions
- GENETIC
-
RNA and DNA Sequencing
DNA and RNA sequencing will be conducted on both control participants and patients with sepsis who are admitted to the ICU.
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
University of California, San Francisco
lead OTHER
Principal Investigators
-
Alexendar R Perez, M.D., Ph.D · University of California, San Francisco
-
Judith Hellman, M.D. · University of California, San Francisco
-
Matthieu Legrand, M.D., Ph.D · University of California, San Francisco
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-02-14
- Primary Completion
- 2028-02-14
- Completion
- 2028-08-14
Countries
- United States
Study Locations
More Related Trials
-
Immunoregulatory Therapy for 2019-nCoV
NCT04268537 ·Status: UNKNOWN ·Phase: PHASE2
-
Identification and Clinical Efficacy Analysis of Biomarkers in Sepsis Patients
NCT05911711 ·Status: UNKNOWN
-
Near Patient Molecular Testing in Sepsis
NCT05469048 ·Status: COMPLETED
-
Assessing Immune Dysfunction in Sepsis
NCT07154615 ·Status: RECRUITING
-
Dynamics of Organ Damage and Immune Exhaustion During Sepsis
NCT06817408 ·Status: RECRUITING
-
MiRNAs Evaluating Lymphocyte Proliferation and Apoptosis as Well as Prognosis of Sepsis
NCT02756559 ·Status: UNKNOWN
-
Effect of Immunophenotype on Prognosis of Sepsis
NCT05602584 ·Status: UNKNOWN
-
Function of Circulating Exosomes in Sepsis-induced Immunosuppression
NCT04979767 ·Status: UNKNOWN
-
REAnimation Low Immune Status Markers
NCT02638779 ·Status: COMPLETED ·Phase: NA
-
TRIM25 in Septic Patients
NCT07320638 ·Status: ENROLLING_BY_INVITATION
-
Genomics in Infection and Sepsis to Predict Organ Dysfunction and Outcomes in Sepsis
NCT04199962 ·Status: UNKNOWN
-
Host Dysregulation-Driven Sepsis Prediction Model
NCT06523075 ·Status: COMPLETED
-
Application of Stimulated Immune Response Change to Predict Outcome of Patient With Severe Sepsis
NCT02887274 ·Status: UNKNOWN
-
SEP-SEQ Trial - Determining the Etiology of Sepsis Using an Infectious Disease Diagnostic Sequencing Assay
NCT02730468 ·Status: COMPLETED
-
MiRNAs Evaluate the Prognosis of Sepsis
NCT01207531 ·Status: UNKNOWN
-
Molecular Subtype-Specific Mechanisms and Therapeutic Strategies in Sepsis
NCT06287684 ·Status: RECRUITING
-
Identification of Markers of Poor Clinical Prognosis in Sepsis by Epigenetic Analysis
NCT06446947 ·Status: RECRUITING
-
Novel Sepsis Sub-phenotypes Based on Trajectories of Vital Signs
NCT05826223 ·Status: COMPLETED
-
Evaluation in the Treatment of Nosocomial Sepsis Comparing Polymerase Chain Reaction With Conventional Blood Culture.
NCT01450358 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration (IMMUNOSEPSIS)
NCT02803346 ·Status: UNKNOWN
-
Comparison of Sepsis Prediction Algorithms
NCT05943938 ·Status: NOT_YET_RECRUITING
-
Personalized Immunotherapy in Sepsis
NCT04990232 ·Status: COMPLETED ·Phase: PHASE2
-
Analysis of Immune Response In Bacterial Infection of Obese Subject
NCT02882568 ·Status: COMPLETED ·Phase: NA
-
A Blood Test to Diagnose Sepsis in Symptomatic Adults and Children
NCT05142813 ·Status: UNKNOWN
-
GM-CSF to Decrease ICU Acquired Infections
NCT02361528 ·Status: COMPLETED ·Phase: PHASE3